Harry W Alcorn Jr is SVP, Clinical Operations of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 43,582 shares of DMAC, which is worth approximately $175,635. The most recent transaction as insider was on Sep 15, 2021, when has been sold 15,000 shares (Voting Common Shares, no par value per share) at a price of $3.8 per share, resulting in proceeds of $57,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.6K
0% 3M change
0% 12M change
Total Value Held $175,635

HARRY W ALCORN Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 15 2021
BUY
Open market or private purchase
$57,000 $3.8 p/Share
15,000 Added 25.61%
43,582 Voting Common Shares, ...
Aug 16 2021
BUY
Open market or private purchase
$62,592 $3.08 p/Share
20,322 Added 41.55%
28,582 Voting Common Shares, ...
HWA

Harry W Alcorn Jr

SVP, Clinical Operations
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Track Activities on DMAC